US Food and Drug Administration (FDA) warned Doctors and their patients were consulted about rare cases of squamous cell carcinoma and various lymphomas developing in scar tissue around breast implants.
The FDA reports fewer than 20 cases of squamous cell carcinoma and less than 30 cases of miscellaneous capsular lymphoma around breast implants. Symptoms may include swelling, pain, lumps or skin changes. These cancers differ from previously described cases of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
Cases have been identified in women who have lived with implants for many years. They placed different types of implants: saline, silicone, textured and smooth.
Although the FDA believes that cases of cancer in the breast implant capsule may be rare, physicians and people considering breast implants should be aware that such cases have been reported. The FDA does not recommend women have their implants removed because of the reported cases. However, patients should monitor their implants and notify the doctor if they notice any changes.